Blood-based mass spectrometry in plasma cell disorders: From residual secretory activity to multimodal residual disease assessment

Critical Reviews in Oncology/Hematology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles